🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate safety and immunogenicity of GSK B...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-01-11
Trial ID
NCT01755689
Treatments Being Tested
Infection with human papillomavirus (HPV) has been clearly established as t...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-01-17
Trial ID
NCT00586339
Treatments Being Tested
Infection with human papillomavirus (HPV) has been clearly established as t...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-04-09
Trial ID
NCT00652938
Treatments Being Tested
This study is designed to evaluate the immunogenicity and safety of GSK Bio...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-02-17
Trial ID
NCT01277042
Treatments Being Tested
Two human papillomavirus vaccines are now commercially available. No clini...
Status
Completed
Location
Laval University Research Hospital Center
Start Date
2008-09
Trial ID
NCT01456715
Infection with human papillomavirus (HPV) has been clearly established as t...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-09-26
Trial ID
NCT00369824
Treatments Being Tested
This phase IV trial tests whether a single dose of the human papillomavirus...
Status
Active Not Recruiting
Location
Agencia Costarricense de Investigaciones Biomédicas (ACIB)
Start Date
2022-03-01
Trial ID
NCT05237947
This protocol posting deals with objectives \& outcome measures of the exte...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-10
Trial ID
NCT00316706
Treatments Being Tested
This is a pilot study of the DRibble vaccine in patients with advanced pros...
Status
Completed
Location
Providence Health & Services
Start Date
2014-10-24
Trial ID
NCT02234921
Treatments Being Tested
This study will assess the risk of spontaneous abortion during weeks 1-19 o...
Status
Terminated
Location
GSK Investigational Site
Start Date
2011-09-26
Trial ID
NCT01290393
Treatments Being Tested